CRISPR Therapeutics
CRSP
#2595
Rank
$4.26 B
Marketcap
$54.44
Share price
0.18%
Change (1 day)
-27.68%
Change (1 year)

Market capitalization of CRISPR Therapeutics (CRSP)

Market cap: $4.26 Billion

As of December 2022 CRISPR Therapeutics has a market cap of $4.26 Billion. This makes CRISPR Therapeutics the world's 2595th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of CRISPR Therapeutics from 2016 to 2022

End of year Market Cap

Year Market cap Change
2022$4.26 B-26.5%
2021$5.79 B-46.81%
2020$10.90 B194.5%
2019$3.70 B149.9%
2018$1.48 B56.74%
2017$0.94 B17.19%
2016$0.80 B

End of Day market cap according to different sources

On Dec 1st, 2022 the market cap of CRISPR Therapeutics was reported to be:

$4.15 Billion
by Yahoo Finance
$4.25 Billion
by CompaniesMarketCap
$4.25 Billion
by Nasdaq
$4.25 Billion
by Iex Cloud

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
$0.15 B-96.34%๐Ÿ‡บ๐Ÿ‡ธ USA